#KidneyWk on X 1 day ago

RT @edgarvlermamd: Treatment of Hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Use of Hypertonic Saline (HTS) 📌 Management of severe…

View Post

#KidneyWk on X 1 day ago

RT @SBNephrology: Growth looks good on this crew 🫘 @ASNKidney #kidneywk https://t.co/nmadTfHwD3

View Post

#KidneyWk on X 2 days ago

RT @Neph_Times: WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #neph…

View Post

#KidneyWk on X 2 days ago

ICYMI: 12-month VISIONARY results show sibeprenlimab sustains proteinuria reduction and remission in IgA nephropathy. #KidneyWk #nephrology #IgAN #...

View Post

#KidneyWk on X 2 days ago

The field of nephrology has seen some exciting innovations thanks to these #KidneyWk award winners. Check out our Q&As to learn more about genetic...

View Post

#KidneyWk on X 3 days ago

RT @Nephronline: Better communication from the care team about the transplant process could encourage more patients to pursue kidney transp…

View Post

#KidneyWk on X 3 days ago

Data presented at @ASNKidney #KidneyWk found lorundrostat with an SGLT2 inhibitor and a renin-angiotensin inhibitor demonstrated efficacy in reduci...

View Post

#KidneyWk on X Wednesday, December 17 @ 2:55 AM

RT @Nephronline: 📞 A pharmacy intervention helped increase SGLT2 inhibitor use for patients with chronic kidney disease and type 2 diabetes…

View Post

#KidneyWk on X Wednesday, December 17 @ 2:00 AM

📞 A pharmacy intervention helped increase SGLT2 inhibitor use for patients with chronic kidney disease and type 2 diabetes, according to data pres...

View Post

#KidneyWk on X Tuesday, December 16 @ 11:01 PM

⏳ Final hours to claim your CME, CNE, CPE credits and MOC points from #KidneyWk 2025. Submit evaluations and share feedback for this year's Early P...

View Post